Reply
arunodayalabs@gmail.com
We have Rivaroxaban USP ready stocks from our GMP facility. Prompt delivery
vishvesh.shaishav@gmail.com
We are focussed on developing new manufacturing technologies, including custom synthesis of new moleculepharma intermediate, catalyst, bulk drugs, pharma API, pharma chemicals, active pharmaceutical ingredients, pharmaceutical pellets,additives, contract manufacturing, chemicals. We began in the field of specialty intermediates for pharmaceutical applications and developed our own purification technologies for manufacturing highly pure intermediates. And Pharmaceutical API At a later stage, we integrated forward to manufacture finished formulations for both veterinary and human consumption. Due to our completely integrated operations in the pharmaceutical sector, we continuously learn about the quality parameters for an API based on the performance of the finished formulation in order to quality their Bioequivalence Studies.?We have established finished formulation lines in South Asian and Latin American countries. It is our vision to achieve worldwide recognition as an excellent business partner from India by providing our customers with superior quality products at highly affordable prices and following that up with reliable service consistently, thereby giving them an unparalleled experience.?Our focus lies in developing new production technologies with a keen interest in frugal innovation in order to gain a competitive edge over others. We specialize in the custom synthesis of molecules and work with many reputed companies around the world on an OEM basis.pharmaceutical pellets,Intermidiates ?Our finished formulations from WHO-GMP and EU-GMP units are registered/being registered in 26 countries within Asia, Europe, North America, Latin America and Africa continents including Peru, Panama, Ecuador, Chile, Curaçao, Suriname, Haiti, Aruba, Trinidad, Tobago, Philippines, Myanmar, Laos, Malaysia, Thailand, Indonesia, Hong Kong, Vietnam, Sri Lanka, Maldives, Brunei, Nepal, China, Russia, Croatia, Venezuela and Bhutan.?vishvesh.shaishav@gmail.com
+919725487108
+919726387108
kunder@bio-synth.co
INTRODUCTION - API & INTERMEDIATES
Me
Wed, 10 Apr 2024 3:33:37 PM +0530
"makpharma4"
Dear sir/Madam,
Greetings from Bio-synth!
We, Biochemical and Synthetic Products Private Limited, INDIA introduce ourselves as one of the leading manufacturers and exporters of various API & Intermediates. Our Plant is accredited with an ISO Certified and also cGMP Compliant with an Installed Capacity of 500 MT per annum.
We are manufacturing below API in our GMP plant
?
1. AMISULPRIDE IP/BP
2. CARVEDILOL IP/BP/USP/EP
3. METOCLOPRAMIDE HCL IP/BP/EP/USP
4. RIVAROXABAN
5. SODIUM AMINO SALICYLATE
6. 4-AMINO SALICYLIC ACID USP(PAS ACID USP)
7. ETHOPABATE BP VET
8. BILASTINE
9. BEDAQUILINE?
?
Presently, we have supplying our API & Intermediates to our domestic and International customers for the past several years.
We enclose herewith our updated API & Intermediates list which we are currently manufacturing in our GMP Plant.
Now we request you to please let us know your requirements to enable us to offer our competitive price
Thanks and regards,
Purushotham Kunder
Dy. Manager
Biochemical and Synthetic Products Pvt. Ltd
Mumbai /Hyderabad
Ph. No./Whatsapp no. +91-9869455944
Email: kunder@bio-synth.com
contact@clearsynthlabs.com
Reply: Rivaroxaban API
Clearsynth Labs is Manufacture/Wholesale Supplier of WHO cGMP, ISO, and GMP quality APIs, Intermediates, Excipients… with CoA, Chemical research… and services from India, UAE, Europe, Canada, US that meet customer and regulatory requirements (USDMF/CEP) compliance at a competitive price. Kindly contact us for your requirement.
Regards
17, Lotus Business Park
Andheri West
Mumbai - 400 053
Maharashtra State
Tel/WhatsApp: +91-8074411410
contact@clearsynthlabs.com
bd1@mehtaapi.com
Mehta API, a 55-year-old manufacturing company with EU GMP, PMDA, and WHO-GMP approvals. We specialize in the production of APIs and intermediates. Currently, we export our APIs to over 40 countries, holding active DMF registrations or filings in key markets such as the EU, China, Japan, Russia, Turkey, and more.
We wish to offer you Rivaroxaban (we also hold CEP for the same). Please send an email at bd1@mehtaapi.com and we will send you all the supporting documents.
